Home » Healthcare » Pharmaceuticals » Marché des métastases osseuses

Marché des métastases osseuses

Marché des métastases osseuses par type (métastases osseuses ostéolytiques, métastases osseuses ostéoblastiques, métastases osseuses mixtes) ; par origine / cancer primaire (cancer du sein, cancer de la prostate, cancer du poumon, cancer du rein, cancer de la thyroïde, autres cancers primaires) ; par diagnostic (imagerie, biopsie, analyses de sang, autres) ; par traitement / thérapie (thérapie pharmacologique, radiothérapie, thérapie médicale systémique, thérapies d’ablation locale/minimale invasive, interventions chirurgicales et orthopédiques, soins de soutien et palliatifs) ; par utilisateur final (hôpitaux et centres de cancérologie, cliniques spécialisées et orthopédiques, cliniques oncologiques communautaires, centres de chirurgie ambulatoire, soins à domicile) ; par région – croissance, part, opportunités et analyse concurrentielle, 2025 – 2032

Résumé
Table des matières
Demander un échantillon gratuit

Demandez un échantillon gratuit

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Demandez votre rapport d’échantillon et commencez votre parcours de décisions éclairées

Fournir la boussole stratégique pour les géants de l’industrie.

Questions Fréquemment Posées :

Quelle est la taille du marché des métastases osseuses en 2025 et les prévisions pour 2032 ?

La taille du marché des métastases osseuses était de 19 984,63 millions USD en 2025 et devrait atteindre 31 260,54 millions USD d’ici 2032.

Quel est le TCAC du marché des métastases osseuses entre 2025 et 2032 ?

Le marché des métastases osseuses devrait croître à un taux de croissance annuel composé (CAGR) de 6,6 % de 2025 à 2032.

Quel est le segment le plus important sur le marché des métastases osseuses ?

L’imagerie est le plus grand segment de diagnostic avec une part estimée à 72,9 % en 2025.

Quels facteurs stimulent la croissance du marché des métastases osseuses ?

La croissance est alimentée par l’augmentation de la prévalence du cancer métastatique, une survie plus longue dans les maladies avancées, des flux de travail de détection et de surveillance guidés par l’imagerie, et l’utilisation croissante de voies de gestion systémique et de soutien des os.

Quelles entreprises sont des participants principaux sur le marché des métastases osseuses ?

Les entreprises clés comprennent Amgen Inc., Novartis AG, F. Hoffmann-La Roche Ltd (Roche), Pfizer Inc., Merck & Co., Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson / Janssen, Medtronic plc, Boston Scientific Corporation, GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., et BTG plc.

Quelle région domine le marché des métastases osseuses ?

L’Amérique du Nord domine le marché des métastases osseuses avec une part estimée à 36,2 % en 2025.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

North America Over-the-Counter (OTC) Drugs Market

The North America Over-the-Counter (OTC) Drugs Market size was valued at USD 72,391.68 MN in 2021 and reached USD 93,061.46 MN in 2025. It is anticipated to reach USD 155,694.86 MN by 2032, growing at a CAGR of 6.49% during the forecast period.

North America Specialty Pharmaceuticals Market

The North America Specialty Pharmaceuticals Market size was valued at USD 67,838.21 MN in 2021 and reached USD 109,086.83 MN in 2025. It is anticipated to reach USD 260,733.67 MN by 2032, growing at a CAGR of 11.03% during the forecast period.

Europe Prescription Drugs Market

The Europe Prescription Drugs Market size was valued at USD 294,866.12 MN in 2021 and reached USD 365,960.68 MN in 2025. It is anticipated to reach USD 553,623.53 MN by 2032, growing at a CAGR of 5.13% during the forecast period.

Cell Therapy Consumables Market

Cell therapy consumables Market was valued at USD 3439 million in 2024 and is anticipated to reach USD 7533.31 million by 2032, growing at a CAGR of 10.3% during the forecast period.

Africa Orphan Drugs Market

The Africa Orphan Drugs Market size was valued at USD 792.75 MN in 2021 and reached USD 1,258.16 MN in 2025. It is anticipated to reach USD 2,826.51 MN by 2032, growing at a CAGR of 6.30% during the forecast period.

Africa Biosimilars Market

The Africa Biosimilars Market size was valued at USD 126.63 MN in 2021 and reached USD 200.98 MN in 2025. It is anticipated to reach USD 451.50 MN by 2032, growing at a CAGR of 7.80% during the forecast period.

Europe Dermatology Drugs Market

The Europe Dermatology Drugs Market size was valued at USD 8,384.62 MN in 2021 and reached USD 10,909.79 MN in 2025. It is anticipated to reach USD 17,933.36 MN by 2032, growing at a CAGR of 6.18% during the forecast period.

North America Pain Management Drugs Market

The North America Pain Management Drugs Market size was valued at USD 11,968.20 MN in 2021 and reached USD 14,314.26 MN in 2025. It is anticipated to reach USD 18,345.24 MN by 2032, growing at a CAGR of 2.85% during the forecast period.

North America Respiratory Drugs Market

The North America Respiratory Drugs Market size was valued at USD 4,603.33 MN in 2021 and reached USD 5,912.29 MN in 2025. It is anticipated to reach USD 8,990.65 MN by 2032, growing at a CAGR of 5.07% during the forecast period.

North America CNS Drugs Market

The North America CNS Drugs Market size was valued at USD 29,971.81 MN in 2021 and reached USD 39,376.62 MN in 2025. It is anticipated to reach USD 64,694.22 MN by 2032, growing at a CAGR of 6.13% during the forecast period.

Asia Pacific Gastrointestinal Drugs Market

The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.

North America Immunology Drugs Market

The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.

Option de licence

Utilisateur unique

$4999

Multi-utilisateur

$5999

Entreprise

$7999

Report delivery within 24 to 48 hours

Que disent les gens?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Scientifique des matériaux
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Assistant de direction, Bekaert

Ils nous font confiance

Request Sample